Tsung Ching Lin
Presidente en GENERAL BIOLOGICALS CORPORATION .
Origen de la red de primer grado Tsung Ching Lin.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
| Subsidiary | Biotechnology | 21 | |
| Public Company | Medical Specialties | 16 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Tsung Ching Lin a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| University of British Columbia | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| Santa Clara University | College/University | Masters Business Admin Masters Business Admin | |
XPhase Pharmaceuticals, Inc.
 XPhase Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology XPhase Pharmaceuticals, Inc. engages in the clinical development of pharmaceuticals. It offers pre-clinical drug development, training and project management services. The company provides services to small & medium pharmaceutical and biotechnology companies in the United States, European Union, Central Eastern Europe, and Asian countries. XPhase Pharmaceuticals was founded in 2007 and is headquartered in Toronto, Canada. | Pharmaceuticals: Major | Chief Executive Officer Founder | |
| National Taiwan University | College/University | Graduate Degree Graduate Degree | |
Calibration & Validation Group
 Calibration & Validation Group Miscellaneous Commercial ServicesCommercial Services Calibration & Validation Group participates with industrial, academic and regulatory bodies to provide technical forums to promote good calibration and validation practices. It offers learning opportunities in analytical, pharmaceutical, environmental and food sciences. The company was founded by Lam Herman, Chung Chow Chan and Yiu-Chung Lee in 1994 and is headquartered in Scarborough, Canada. | Miscellaneous Commercial Services | Founder Corporate Officer/Principal | |
Deserving Health International Corp.
 Deserving Health International Corp. Financial ConglomeratesFinance Deserving Health International Corp. develops natural skin care and personal care products. It also provides baby care products. The firm offers its products under the brands Symbiopathic, Dermamed and BioIQ Diagnostics. The company was founded by Bernard Armani on August 26, 2013 by Bernard Armani and is headquartered in Richmond, Canada. | Financial Conglomerates | Director/Board Member Director of Finance/CFO | |
| Chung Yuan Christian University | College/University | Undergraduate Degree Masters Business Admin | |
| Purdue University | College/University | Undergraduate Degree Undergraduate Degree | |
| TRILLIUM THERAPEUTICS | Biotechnology | President Corporate Officer/Principal | |
| Beedie School of Business | College/University | Masters Business Admin Masters Business Admin | |
| CORREVIO PHARMA CORP. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
Protevobio, Inc.
 Protevobio, Inc. Miscellaneous Commercial ServicesCommercial Services Protevobio, Inc. provides biotechnology research services. The private company is based in Sunnyvale, CA. The company was founded by Jeng-Horng Her. | Miscellaneous Commercial Services | Chief Executive Officer | |
| WESTERN MAGNESIUM CORPORATION | Chemicals: Specialty | Director of Finance/CFO | |
Multispan, Inc.
 Multispan, Inc. BiotechnologyHealth Technology Multispan, Inc. develops assay tools for G-protein coupled receptor (GPCR) for research applications. It offers GPCR cell line reagents for drug screening assays, compound profiling, and monoclonal antibody generation. The firm also offers GPCR cDNA Bank that provides clones for GPCR expression in mammalian cells; and high expression cell lines, as well as cell line development services. The company was founded by Helena Suyang Mancebo and Jeng-Horng Her in 2004 and is headquartered in Hayward, CA. | Biotechnology | Founder | |
| PHARMATHER HOLDINGS LTD. | Pharmaceuticals: Major | Director/Board Member | |
| University of Virginia | College/University | Doctorate Degree | |
| North Carolina State University | College/University | Masters Business Admin | |
| AP BIOSCIENCES INC | Biotechnology | Founder | |
| HUMANIGEN, INC. | Biotechnology | Founder | |
| SYSTEMS & TECHNOLOGY CORP | Telecommunications Equipment | Director/Board Member | |
Eli Lilly Canada, Inc.
 Eli Lilly Canada, Inc. Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Eli Lilly Canada, Inc. is a healthcare leader that focuses on oncology, diabetes, autoimmunity, neurodegeneration, and pain. The company is based in Scarborough, Canada. Established in 1938, the Canadian company collaborates with scientists to produce innovative medicines that make life better for people around the world. The company's mission is to discover and bring life-changing medicines to people who need them, improve the understanding and management of disease, and contribute to communities through philanthropy and volunteerism. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Systems & Technology (Beijing) Co. Ltd. | Director/Board Member | ||
| CHLITINA HOLDING LIMITED | Household/Personal Care | Chief Executive Officer | |
| Tongji University | College/University | Graduate Degree | |
| REVIVE THERAPEUTICS LTD. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Shanghai Rarestone Health Tech Group Co. Ltd.
 Shanghai Rarestone Health Tech Group Co. Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Rarestone Health Tech Group Co. Ltd. is a Chinese company that focuses on rare disease therapy and self-management information through internet information. The company is based in Huangpu, China. The company also operates and promote medical devices and communication platforms. The CEO of the company is Shawn Xiang. | Pharmaceuticals: Major | Director/Board Member | |
Ironshore Pharmaceutical & Development, Inc.
 Ironshore Pharmaceutical & Development, Inc. BiotechnologyHealth Technology Part of Ironshore Therapeutics, Inc., Ironshore Pharmaceutical & Development, Inc. develops novel therapeutics using its proprietary controlled-release drug-delivery technology. The company is based in Camana Bay, Cayman Islands. Our lead products are developed using a unique and beneficial delayed-release and extended-release delivery to a specifically targeted area. Ironshore is a fully Caymanian integrated pharmaceutical company with experience developing and commercializing first-in-class therapeutic products. JORNAY PM is a first-in-class product indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years and older. The company is committed to the development and commercialization of first-in-class treatment options to improve the lives of patients and caregivers. The CEO of the company is David Gordon MacLeod Lickrish. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| Shanghai Jiao Tong University | College/University | Undergraduate Degree | |
Waterstone Pharmaceuticals, Inc.
 Waterstone Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Waterstone Pharmaceuticals, Inc. engages in the provision of discovery, development, and commercialization of innovative drugs for the treatment of liver and gastrointestinal diseases. The company was founded by Faming Zhang in 2008 and is headquartered in Carmel, IN. | Pharmaceuticals: Major | Chief Operating Officer | |
| TAIWAN LIPOSOME COMPANY, LTD. | Pharmaceuticals: Major | Director/Board Member | |
| Burrill & Co. Venture Capital | Chief Executive Officer | ||
| China Healthcare Consortium Ltd. | Director/Board Member | ||
| The BayHelix Group | Corporate Secretary | ||
| ZAI LAB LIMITED | Biotechnology | Founder | |
Crescendo Biologics Ltd.
 Crescendo Biologics Ltd. Miscellaneous Commercial ServicesCommercial Services Crescendo Biologics Ltd. engages in the development of new medicines based on antibody fragment technology. Its products in pipeline in dermatology include CB001, a transformational Humabody-based topical biologic for psoriasis which combines exceptional activity against a validated target with a topical route of delivery to avoid systemic side effects. The firm?s oncology products in pipeline include Humabody Multi-Specific T-Cell Engagers, Humabody Antibody Drug Conjugates and Immune Checkpoint Inhibitors. The company was founded by Michael Anthony Romanos, David Rayll Brown and John Bradshaw on November 13, 2007 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Concept 2 Clinic, Inc.
 Concept 2 Clinic, Inc. Miscellaneous Commercial ServicesCommercial Services Concept 2 Clinic, Inc. operates as an executive research and development management company that specializes in pharmaceutical and biotechnology sectors. Its services include financial, opportunity assessment, pre-clinical and CMC. The company is headquartered in Markham, Canada. | Miscellaneous Commercial Services | President | |
Jing Medicine Technology Shanghai Ltd.
 Jing Medicine Technology Shanghai Ltd. BiotechnologyHealth Technology Jing Medicine Technology Shanghai Ltd. develops therapeutic monoclonal antibody and small molecule drugs. The private company is based in Shanghai, China. | Biotechnology | Director/Board Member | |
MEDx Translational Medicine Co., Ltd.
 MEDx Translational Medicine Co., Ltd. Medical DistributorsDistribution Services MEDx Translational Medicine Co., Ltd. is a leading Chinese innovative company in companion diagnostics and precision medicine in China. The company is based in Suzhou, China. MEDx collaborates with hundreds of world-renowned pharmaceutical companies and has been rewarded with many certifications, including China CNAS, ISO17025, and US CAP ISO 13485, among others. The company was founded in 2013 as Qiagen Translational Medicine Co., Ltd. With comprehensive technology platforms, high-quality systems, and strong IVD R&D experience, MEDx offers integrated solutions from biomarker discovery to patient stratification for drug clinical trials, IVD/CDX R&D, and commercialization. The company was founded in 2013 by Ya Fei Zhang, who has been the CEO since then. | Medical Distributors | Director/Board Member | |
Kira Pharmaceuticals (Hong Kong) Ltd.
 Kira Pharmaceuticals (Hong Kong) Ltd. Pharmaceuticals: MajorHealth Technology Kira Pharmaceuticals (Hong Kong) Ltd. manufactures pharmaceuticals. The private company is based in Hong Kong, Hong Kong. | Pharmaceuticals: Major | Director/Board Member | |
Innoforce Pharmaceuticals Co. Ltd.
 Innoforce Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Innoforce Pharmaceuticals Co. Ltd. is a bioinnovation-enabling corporation located in the Hangzhou Bay Biotech Valley within the Hangzhou Airport Economic Demonstration Area. The founders and core management team have extensive international experience and expertise in technology innovation, product development, and business operations. The Chinese company's first phase of the campus covers 21 acres, including biologic process development laboratories, scale-up and R & D labs, and manufacturing facilities for protein, cell, and gene therapies. The company was founded in 2018 by Guo-Liang Yu, Yuling Li, and Zhenhua Wu. Dewan Zeng has been the CEO of the company since 2023. | Pharmaceuticals: Major | Director/Board Member | |
| Chlitina International Ltd. | Director/Board Member | ||
Eluminex Biosciences (Suzhou) Ltd.
 Eluminex Biosciences (Suzhou) Ltd. BiotechnologyHealth Technology Eluminex Biosciences (Suzhou) Ltd. is a privately held biotechnology company located in Suzhou, China. Eluminex Biosciences is committed to developing innovative pharmaceuticals, drug delivery systems, and regenerative tissue for significant unmet vision-threatening or lifestyle limiting ophthalmic diseases in various markets. The Chinese company focuses on ophthalmology and recombinant human collagen technology, with a goal to become a leading healthcare company in developing irreversible loss of optical quality of the cornea due to disease or damage, diabetic macular edema, and wet age-related macular degeneration. The company was founded in 2020 by Jin Zhong Zhang, who has been the CEO since then. | Biotechnology | Director/Board Member | |
| University of Guelph | College/University | Doctorate Degree | |
| Chlitina Group Ltd. | Director/Board Member | ||
| Chlitina Marketing Ltd. | Director/Board Member | ||
| Chlitina Intelligence Ltd. | Director/Board Member | ||
| Temple University (Pennsylvania) | College/University | Doctorate Degree | |
| Soochow University /Taiwan/ | College/University | Graduate Degree | |
| ARBUTUS BIOPHARMA CORPORATION | Pharmaceuticals: Major | Investor Relations Contact |
Estadísticas
Internacional
| Canadá | 14 |
| Estados Unidos | 14 |
| China | 10 |
| Taiwán | 8 |
| Hong-Kong | 3 |
Sectorial
| Health Technology | 20 |
| Consumer Services | 14 |
| Commercial Services | 5 |
| Electronic Technology | 3 |
| Finance | 2 |
Operativa
| Director/Board Member | 109 |
| Independent Dir/Board Member | 26 |
| Chairman | 24 |
| Corporate Officer/Principal | 20 |
| Chief Executive Officer | 16 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Ming-Chih Hsuan | 28 |
| Chung Yue Wang | 23 |
| Pi Hua Chen | 22 |
| Marietta Wu | 19 |
| Alan Savage | 16 |
| Kevin McGarry | 9 |
| Beverly Incledon | 8 |
| Rakesh Kumar Arya | 7 |
| Ming Shan Liu | 7 |
| Jeng-Horng Her | 6 |
| Alan Moore | 6 |
| Christina Yip | 6 |
| Che Jen Chuang | 6 |
| Chia Shang Chen | 5 |
| Sudhir Sharma | 4 |
- Bolsa de valores
- Insiders
- Tsung Ching Lin
- Conexiones Empresas
